Article thumbnail

A New Extensively Characterised Conditionally Immortal Muscle Cell-Line for Investigating Therapeutic Strategies in Muscular Dystrophies

By Sofia Muses, Jennifer E. Morgan and Dominic J. Wells

Abstract

A new conditionally immortal satellite cell-derived cell-line, H2K 2B4, was generated from the H2Kb-tsA58 immortomouse. Under permissive conditions H2K 2B4 cells terminally differentiate in vitro to form uniform myotubes with a myogenic protein profile comparable with freshly isolated satellite cells. Following engraftment into immunodeficient dystrophin-deficient mice, H2K 2B4 cells regenerated host muscle with donor derived myofibres that persisted for at least 24 weeks, without forming tumours. These cells were readily transfectable using both retrovirus and the non-viral transfection methods and importantly upon transplantation, were able to reconstitute the satellite cell niche with functional donor derived satellite cells. Finally using the Class II DNA transposon, Sleeping Beauty, we successfully integrated a reporter plasmid into the genome of H2K 2B4 cells without hindering the myogenic differentiation. Overall, these data suggest that H2K 2B4 cells represent a readily transfectable stable cell-line in which to investigate future stem cell based therapies for muscle disease

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3173493
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). 16 The Sleeping Beauty Transposon system for treatment of mucopolysaccharidoses.
  2. (2007). A population of myogenic stem cells that survives skeletal muscle aging.
  3. (2010). Advanced maturation by electrical stimulation: Differences in response between C2C12 and primary muscle progenitor cells.
  4. (2007). Asymmetric self-renewal and commitment of satellite stem cells in muscle.
  5. (2002). Common physical properties of DNA affecting target site selection of Sleeping Beauty and other Tc1/mariner transposable elements.
  6. (2010). Comparison of satellite cell-derived myoblasts and C2C12 differentiation in twoand three-dimensional cultures: changes in adhesion protein expression.
  7. (2011). Contribution of human muscle-derived cells to skeletal muscle regeneration in dystrophic host mice.
  8. (1989). Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.
  9. (1991). Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse.
  10. (2007). Dissociated flexor digitorum brevis myofiber culture system–a more mature muscle culture system.
  11. (1999). Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem celllike properties as the myogenic source.
  12. (2000). Evidence for a myogenic stem cell that is exhausted in dystrophic muscle.
  13. (1992). Formation of skeletal muscle in vivo from the mouse C2 cell line.
  14. (2010). Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells. Mol Ther 18: 1803–1813. Epub
  15. (2009). Hybrid Lentivirus-transposon Vectors With a Random Integration Profile in Human Cells.
  16. (2009). Isolation and grafting of single muscle fibres.
  17. (2007). Messenger RNA as a source of transposase for sleeping beauty transposonmediated correction of hereditary tyrosinemia type I.
  18. (2009). Microwave irradiation enhances gene and oligonucleotide delivery and induces effective exon skipping in myoblasts.
  19. (2009). Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.
  20. (1997). Molecular reconstruction of Sleeping beauty, a Tc1-like transposon from fish, and its transposition in human cells.
  21. MorganJE,Gross JG,Pagel CN,BeauchampJR,FassatiA,etal.(2002)Myogenic cell proliferation and generation of a reversible tumorigenic phenotype are triggered by preirradiation of the recipient site.
  22. (1999). Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury.
  23. (2004). Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?
  24. (2010). Muscle satellite cells are a functionally heterogeneous population in both somite-derived and branchiomeric muscles.
  25. (1994). Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines.
  26. (1999). Patterns of repair of dystrophic mouse muscle: studies on isolated fibers.
  27. (2004). Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal.
  28. (1997). Preferential Adhesion to and Survival on Patterned Laminin Organizes Myogenesisin Vitro.
  29. (2007). Prolonged expression of a lysosomal enzyme in mouse liver after Sleeping Beauty transposon-mediated gene delivery: implications for non-viral gene therapy of mucopolysaccharidoses.
  30. (2004). Regeneration of skeletal muscle from transplanted immortalised myoblasts is oligoclonal.
  31. (1991). Retroviralmediated gene transfer into hepatocytes in vivo.
  32. (2006). RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.
  33. (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.
  34. (1997). Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells.
  35. (2009). Sleeping Beauty Transposition From Nonintegrating Lentivirus.
  36. (2005). Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche.
  37. (2002). Structure-function analysis of the inverted terminal repeats of the sleeping beauty transposon.
  38. (2006). Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.
  39. (2009). Systemic correction of storage disease in MPS I NOD/SCID mice using the sleeping beauty transposon system.
  40. (2005). Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in bodywide skeletal muscles.
  41. (2009). The Mature Adult Dystrophic Mouse Muscle Environment Does Not Impede Efficient Engrafted Satellite Cell Regeneration And Self-Renewal.
  42. (2004). Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status.
  43. (1993). Transactivation of the murine dystrophin gene in human-mouse hybrid myotubes.
  44. (1984). X chromosome-linked muscular dystrophy (mdx) in the mouse.